Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 133. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_323Canine parvovirusCPV2.NS1DNAParoviridaeCPV genome expressing non-structural protein (NS1)YesNoNoNCCS (National Centre for Cell Science, Pune, India)Human cervical cancer cell lineHeLadensity of E+4 to E+5 cells/well in 120 microlitres of culture mediumNALDH assayNA9% cancer cell death at 24 hoursNoNoNA No responseNAApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9NANA26555166
OV_324Canine parvovirusCPV2.NS1DNAParoviridaeCPV genome expressing non-structural protein (NS1)YesNoNoNCCS (National Centre for Cell Science, Pune, India)Human cervical cancer cell lineHeLadensity of E+4 to E+5 cells/well in 120 microlitres of culture mediumNALDH assayNA18% cancer cell death at 48 hoursNoNoNA No responseNAApoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9NANA26555166
OV_607AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15ATCCHuman cervical cancer cellHeLa1.0E+5 cells per wellNAMTT assay0.1 MOI85% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_610AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15ATCCHuman cervical cancer cellHeLa1.0E+5 cells per wellNAMTT assay1 MOI37% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_613AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15ATCCHuman cervical cancer cellHeLa1.0E+5 cells per wellNAMTT assay10 MOI8% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_616AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15ATCCHuman cervical cancer cellHeLa1.0E+5 cells per wellNAMTT assay50 MOI5% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_1106Sindbis virusAR339RNATogaviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI50% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1107Sindbis virusAR339RNATogaviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI35% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1108Sindbis virusAR339RNATogaviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI15% cell viablityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1121Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI50% cell viablityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1122Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI30% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1123Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm1MOI25% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_3045Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3046Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3047Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3075Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3076Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3077Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman cervical cancer cell lineHeLa3.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3661Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI75% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3662Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI68% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3677Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI100% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3678Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI70% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3693Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI75% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3694Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman cervix cancer cell lineHeLa5000 cells per wellNAMTT assay1 MOI70% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3803Newcastle disease virusNDVstrain 777RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU18% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3804Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU22% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3805Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU23% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3806Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU23% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3807Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU25% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3808Newcastle disease virusNDVstrain 860RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU26% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3809Newcastle disease virusNDVstrain 14RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU42% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3810Newcastle disease virusNDVstrain 769RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU45% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3811Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU45% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3812Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU60% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3813Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU60% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3814Newcastle disease virusNDVstrain ADRNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU62% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3815Newcastle disease virusNDVstrain 429RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU65% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3816Newcastle disease virusNDVstrain 27RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU65% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3817Newcastle disease virusNDVstrain 718RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU65% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3818Newcastle disease virusNDVstrain 49RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU68% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3819Newcastle disease virusNDVstrain 52RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU68% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3820Newcastle disease virusNDVstrain 329RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU75% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3821Newcastle disease virusNDVstrain 12RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU75% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3822Newcastle disease virusNDVstrain 53RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU79% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3823Newcastle disease virusNDVstrain 746RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU79% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3824Newcastle disease virusNDVstrain 389RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU82% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3825Newcastle disease virusNDVstrain 339RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU85% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3826Newcastle disease virusNDVstrain 922RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU90% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3827Newcastle disease virusNDVstrain 945RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU95% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3828Newcastle disease virusNDVstrain 753RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3829Newcastle disease virusNDVstrain 48RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3830Newcastle disease virusNDVstrain 465RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3908Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3909Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU23% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3910Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3911Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU67% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3912Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU64% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3913Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU59% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3914Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU29% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3915Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU24% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3916Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU24% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3917Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU25% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3918Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU21% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3919Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3920Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU32% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3921Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU24% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3922Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU21% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3923Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU56% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3924Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU51% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3925Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3926Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU51% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3927Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU52% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3928Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU47% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3929Newcastle disease virusNDVstrain 769RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU51% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3930Newcastle disease virusNDVstrain 769RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU47% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3931Newcastle disease virusNDVstrain 769RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU46% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3932Newcastle disease virusNDVstrain 860RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU28% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3933Newcastle disease virusNDVstrain 860RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3934Newcastle disease virusNDVstrain 860RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU25% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3935Newcastle disease virusNDVstrain 777RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU19% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3936Newcastle disease virusNDVstrain 777RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU17% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3937Newcastle disease virusNDVstrain 777RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU17% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3938Newcastle disease virusNDVstrain 14RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU61% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3939Newcastle disease virusNDVstrain 14RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU61% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3940Newcastle disease virusNDVstrain 14RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU41% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3995Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3996Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU24% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3997Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4007Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU70% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4008Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU65% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4009Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4019Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4020Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU25% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4021Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU24% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4031Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU25% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4032Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4033Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4043Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4044Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4045Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4055Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4056Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4057Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4067Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4068Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4069Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU45% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4304AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman cervix adenocarcinomaHeLa4000 cells per wellNAMTT assay10 pfu66 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4427Vesicular stomatitis virusRdBRNARhabdoviridaeVirus expressing VSVG epitope, with no dletion in HI-loop, no addition of linkerYesNoNoATCCHuman cervical cancer cell lineHeLa1.2E+4 cells per wellNAMTT assay21:1 particle to pfu60% cell survival after 4 daysNoNoNA No responseNANANANA26430798
OV_4435Vesicular stomatitis virusRdB-1L-VSVGRNARhabdoviridaeVirus expressing VSVG epitope, with no dletion in HI-loop, addition of single linkerYesNoNoATCCHuman cervical cancer cell lineHeLa1.2E+4 cells per wellNAMTT assay24:1 particle to pfu20% cell survival after 4 daysNoNoNA No responseNANANANA26430798
OV_4885Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay0.1 MOI100% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4886Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay1 MOI98% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4887Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay10 MOI88% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4888Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay50 MOI88% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4889Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay0.1 MOI90% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4890Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay1 MOI50% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4891Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay10 MOI10% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4892Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay50 MOI100% cell killing aftwr 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4893Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay0.1 MOI80% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4894Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay1 MOI20% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4895Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay10 MOI10% cell viability after 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4896Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneATCCHuman cervix epithelial adenocarcinoma cell lineHeLa1 million cells per wellNAMTT assay50 MOI100% cell killing aftwr 7 daysNoNoSlightly toxic to HeLa as measured by LDH assay No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_5066Avian orthoreovirusARV-PB1RNAReoviridaeNoneYesNoNoATCCHuman cervical cancer cell lineHeLa1.0E+3 cells per wellNACrystal violet staining10 MOI50% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28441762
OV_5196Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI100% cell viable after 24 hoursNoNoNA No responseNANANANA27760834
OV_5197Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI100% cell viable after 48 hoursNoNoNA No responseNANANANA27760834
OV_5198Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI80% cell viable after 72 hoursNoNoNA No responseNANANANA27760834
OV_5199AdenovirusTRAD-shLucDNAAdenoviridaeVirus having shorthairpin RNA for Luciferase gene knockoutYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI100% cell viable after 24 hoursNoNoNA No responseNANANANA27760834
OV_5200AdenovirusTRAD-shLucDNAAdenoviridaeVirus having shorthairpin RNA for Luciferase gene knockoutYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI100% cell viable after 48 hoursNoNoNA No responseNANANANA27760834
OV_5201AdenovirusTRAD-shLucDNAAdenoviridaeVirus having shorthairpin RNA for Luciferase gene knockoutYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI80% cell viable after 72 hoursNoNoNA No responseNANANANA27760834
OV_5202AdenovirusTRAD-shDICERDNAAdenoviridaeVirus having shorthairpin RNA for DICERYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI100% cell viable after 24 hoursNoNoNA No responseNANANANA27760834
OV_5203AdenovirusTRAD-shDICERDNAAdenoviridaeVirus having shorthairpin RNA for DICERYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI60% cell viable after 24 hoursNoNoNA No responseNANANANA27760834
OV_5204AdenovirusTRAD-shDICERDNAAdenoviridaeVirus having shorthairpin RNA for DICERYesNoNoJCRB cell bankHuman epithelia carcinoma cell lineHeLaNAToxic to normal human cell line above 10 MOIAlamar blue assay2 MOI10% cell viable after 24 hoursNoNoNA No responseNANANANA27760834
OV_5621Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman cervical carcinoma cell lineHeLa80% confluencyNAMTT assay4 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5841Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman cervical carcinoma cell lineHeLa80% confluencyNANA4 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578